Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04300790
Title Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients (METALLICA)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors MedSIR
Indications

Her2-receptor negative breast cancer

Therapies

Alpelisib + Fulvestrant + Metformin

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST